Ralitza H. Gavrilova, M.D., is an expert in clinical genomics and neurology whose research areas of interest are in the fields of mitochondrial medicine and neurogenetics. Dr. Gavrilova studies mitochondrial myopathy, multisystemic mitochondrial diseases, Friedreich's ataxia and neurodegenerative conditions that involve mitochondrial dysfunction, such as dementia. Another area of Dr. Gavrilova's clinical focus is hereditary leukodystrophies. Dr. Gavrilova's research goal is to improve understanding of mitochondrial dysfunction in disease.
- Mitochondrial diseases
- Friedreich's ataxia
- Neurodegenerative diseases with mitochondrial dysfunction
Significance to patient care
Dr. Gavrilova's hope is that her research leads to improvements in quality of life for patients with mitochondrial diseases and related conditions by facilitating better and new diagnostic and evaluation approaches. Dr. Gavrilova also hopes to help patients by developing new therapies and clinical trials for unmet patient needs.
- Board member, United Mitochondrial Disease Foundation, 2020-present
- Director, Mayo Clinic Mitochondrial Care Center, 2019-present
- Board member, Mitochondrial Medicine Society, 2019-present
- Principal investigator, Mayo Clinic patient registry site, North American Mitochondrial Disease Consortium, 2011-present
- Biobank committee chair, North American Mitochondrial Disease Consortium, 2011-present